» Articles » PMID: 29213174

X-linked Hypophosphatemic Rickets (PHEX Mutation): A Case Report and Literature Review

Overview
Specialty Pediatrics
Date 2017 Dec 8
PMID 29213174
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Hypophosphatemic rickets is a rare form of rickets that affect children. The diagnosis requires high index of suspicion. We report a case of Hypophosphatemic rickets in 18-month-old Saudi boy presented with delayed walking and lower limb deformity. The diagnosis was confirmed by bone profile, radiological study and genetic testing, which reveled PHEX mutation. The patient was successfully treated by phosphate supplement.

Citing Articles

Use of Whole-Exome Sequencing and Pedigree Analysis to Identify X-linked Hypophosphatemia in Saudi Arabian Families.

Al-Hamed M, Bakhamis S, Abdelfattah S, Alsagheir A J Endocr Soc. 2024; 9(1):bvae203.

PMID: 39659542 PMC: 11631126. DOI: 10.1210/jendso/bvae203.


Lessons learned from the real-world diagnosis and management of hereditary hypophosphatemic rickets.

Chaturvedi D, Mehasi T, Benbrahim A, ElDeeb L, Deeb A Bone Rep. 2024; 21:101753.

PMID: 39011543 PMC: 11247149. DOI: 10.1016/j.bonr.2024.101753.


Diagnostic and New Therapeutic Approaches to Two Challenging Pediatric Metabolic Bone Disorders: Hypophosphatasia and X-linked Hypophosphatemic Rickets.

Aljuraibah F, Alalwan I, Habeb A Curr Pediatr Rev. 2023; 20(4):395-404.

PMID: 37927073 DOI: 10.2174/0115733963206838231031102750.


Effects of Burosumab Treatment on Two Siblings with X-Linked Hypophosphatemia. Case Report and Literature Review.

Jurca C, Iuhas O, Kozma K, Petchesi C, Zaha D, Bembea M Genes (Basel). 2022; 13(8).

PMID: 36011303 PMC: 9407333. DOI: 10.3390/genes13081392.


Diagnosis and management of X-linked hypophosphatemia in children and adolescent in the Gulf Cooperation Council countries.

Juraibah F, Al Amiri E, Al Dubayee M, Al Jubeh J, Al Kandari H, Al Sagheir A Arch Osteoporos. 2021; 16(1):52.

PMID: 33660084 PMC: 7929956. DOI: 10.1007/s11657-021-00879-9.


References
1.
Weber T, Liu S, Indridason O, Quarles L . Serum FGF23 levels in normal and disordered phosphorus homeostasis. J Bone Miner Res. 2003; 18(7):1227-34. DOI: 10.1359/jbmr.2003.18.7.1227. View

2.
Makitie O, Toiviainen-Salo S, Marttinen E, Kaitila I, Sochett E, Sipila I . Metabolic control and growth during exclusive growth hormone treatment in X-linked hypophosphatemic rickets. Horm Res. 2008; 69(4):212-20. DOI: 10.1159/000113021. View

3.
Igaki J, Yamada M, Yamazaki Y, Koto S, Izawa M, Ariyasu D . High iFGF23 level despite hypophosphatemia is one of the clinical indicators to make diagnosis of XLH. Endocr J. 2011; 58(8):647-55. DOI: 10.1507/endocrj.k10e-257. View

4.
Martin A, David V, Quarles L . Regulation and function of the FGF23/klotho endocrine pathways. Physiol Rev. 2012; 92(1):131-55. PMC: 3306265. DOI: 10.1152/physrev.00002.2011. View

5.
Seikaly M, Brown R, Baum M . The effect of recombinant human growth hormone in children with X-linked hypophosphatemia. Pediatrics. 1997; 100(5):879-84. DOI: 10.1542/peds.100.5.879. View